Search

Your search keyword '"Chinnaiyan, Arul M"' showing total 91 results

Search Constraints

Start Over You searched for: Author "Chinnaiyan, Arul M" Remove constraint Author: "Chinnaiyan, Arul M" Publisher elsevier inc. Remove constraint Publisher: elsevier inc.
91 results on '"Chinnaiyan, Arul M"'

Search Results

2. CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13

3. Development of an orally bioavailable CDK12/13 degrader and induction of synthetic lethality with AKT pathway inhibition

4. Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance

5. Targeting the mSWI/SNF complex in POU2F-POU2AF transcription factor-driven malignancies

8. Comprehensive proteogenomic characterization of rare kidney tumors

9. Pan-cancer proteogenomics characterization of tumor immunity

10. Deep learning integrates histopathology and proteogenomics at a pan-cancer level

11. Proteogenomic insights suggest druggable pathways in endometrial carcinoma

12. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation

13. Pan-cancer proteogenomics connects oncogenic drivers to functional states

14. Proteogenomic data and resources for pan-cancer analysis

18. TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma

19. Invasive squamous cell carcinomas and precursor lesions on UV-exposed epithelia demonstrate concordant genomic complexity in driver genes

23. Corrigendum to “Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma” [Neoplasia, Volume 21, Issue 3 (2019) 322–330]

25. Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate Cancer

26. Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays

27. Corrigendum to “Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma” [Neoplasia, Volume 21, Issue 3 (2019) 322–330]

33. Development and Validation of a Scalable Next-Generation Sequencing System for Assessing Relevant Somatic Variants in Solid Tumors

38. HRAS mutations are frequent in inverted urothelial neoplasms

42. KRAS Protein Stability Is Regulated through SMURF2: UBCH5 Complex-Mediated β-TrCP1 Degradation

50. Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer

Catalog

Books, media, physical & digital resources